Does the media prefer G or CCRN?

In the previous week, Genpact and Genpact both had 8 articles in the media. Genpact's average media sentiment score of 0.51 beat Cross Country Healthcare's score of 0.50 indicating that Genpact is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Genpact 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Cross Country Healthcare 2 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation and earnings, G or EXLS?

Genpact has higher revenue and earnings than ExlService. Genpact is trading at a lower price-to-earnings ratio than ExlService, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Genpact $5.08B 1.00 $552.49M $3.26 9.21 ExlService $2.09B 1.96 $251.02M $1.57 17.09

Is G or EXLS more profitable?

ExlService has a net margin of 11.66% compared to Genpact's net margin of 11.04%. ExlService's return on equity of 28.50% beat Genpact's return on equity. Company Net Margins Return on Equity Return on Assets Genpact 11.04% 22.70% 10.42% ExlService 11.66% 28.50% 15.48%

Does the media prefer G or EXLS?

In the previous week, Genpact had 5 more articles in the media than ExlService. MarketBeat recorded 8 mentions for Genpact and 3 mentions for ExlService. ExlService's average media sentiment score of 0.82 beat Genpact's score of 0.51 indicating that ExlService is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Genpact 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive ExlService 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor G or BR?

In the previous week, Broadridge Financial Solutions had 11 more articles in the media than Genpact. MarketBeat recorded 19 mentions for Broadridge Financial Solutions and 8 mentions for Genpact. Broadridge Financial Solutions' average media sentiment score of 1.06 beat Genpact's score of 0.51 indicating that Broadridge Financial Solutions is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Genpact 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Broadridge Financial Solutions 12 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer G or JKHY?

In the previous week, Genpact had 2 more articles in the media than Jack Henry & Associates. MarketBeat recorded 8 mentions for Genpact and 6 mentions for Jack Henry & Associates. Jack Henry & Associates' average media sentiment score of 1.10 beat Genpact's score of 0.51 indicating that Jack Henry & Associates is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Genpact 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Jack Henry & Associates 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Which has preferable earnings & valuation, G or WEX?

Genpact has higher revenue and earnings than WEX. Genpact is trading at a lower price-to-earnings ratio than WEX, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Genpact $5.08B 1.00 $552.49M $3.26 9.21 WEX $2.66B 2.03 $304.10M $8.91 17.50

Is G or WEX more profitable?

WEX has a net margin of 11.50% compared to Genpact's net margin of 11.04%. WEX's return on equity of 42.66% beat Genpact's return on equity. Company Net Margins Return on Equity Return on Assets Genpact 11.04% 22.70% 10.42% WEX 11.50% 42.66% 3.33%

Does the media favor G or WEX?

In the previous week, WEX had 11 more articles in the media than Genpact. MarketBeat recorded 19 mentions for WEX and 8 mentions for Genpact. WEX's average media sentiment score of 0.52 beat Genpact's score of 0.51 indicating that WEX is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Genpact 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive WEX 5 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Genpact (G) Competitors

$30.02 -0.17 (-0.55%)

Closing price 03:59 PM Eastern

Extended Trading

$30.03 +0.02 (+0.05%)

As of 07:49 PM Eastern

Compare

G vs. CCRN, EXLS, BR, JKHY, and WEX

Should you buy Genpact stock or one of its competitors? MarketBeat compares Genpact with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Genpact include Cross Country Healthcare (CCRN), ExlService (EXLS), Broadridge Financial Solutions (BR), Jack Henry & Associates (JKHY), and WEX (WEX).

How does Genpact compare to Cross Country Healthcare?

Genpact (NYSE:G) and Cross Country Healthcare (NASDAQ:CCRN) are related companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, profitability, dividends, risk and media sentiment.

Genpact has a net margin of 11.04% compared to Cross Country Healthcare's net margin of -9.84%. Genpact's return on equity of 22.70% beat Cross Country Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Genpact	11.04%	22.70%	10.42%
Cross Country Healthcare	-9.84%	-0.74%	-0.54%

Genpact has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market. Comparatively, Cross Country Healthcare has a beta of 0.45, suggesting that its share price is 55% less volatile than the broader market.

96.0% of Genpact shares are held by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are held by institutional investors. 1.6% of Genpact shares are held by company insiders. Comparatively, 6.3% of Cross Country Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Genpact currently has a consensus target price of $40.25, suggesting a potential upside of 34.10%. Cross Country Healthcare has a consensus target price of $12.05, suggesting a potential downside of 9.06%. Given Genpact's stronger consensus rating and higher possible upside, equities research analysts plainly believe Genpact is more favorable than Cross Country Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genpact	0 Sell rating(s)	6 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Cross Country Healthcare	1 Sell rating(s)	9 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.90

Genpact has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Genpact, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genpact	$5.08B	1.00	$552.49M	$3.26	9.21
Cross Country Healthcare	$1.00B	0.43	-$94.85M	-$3.05	N/A

In the previous week, Genpact and Genpact both had 8 articles in the media. Genpact's average media sentiment score of 0.51 beat Cross Country Healthcare's score of 0.50 indicating that Genpact is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Genpact	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Cross Country Healthcare	2 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Genpact beats Cross Country Healthcare on 14 of the 15 factors compared between the two stocks.

How does Genpact compare to ExlService?

Genpact (NYSE:G) and ExlService (NASDAQ:EXLS) are both mid-cap computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, media sentiment, risk and analyst recommendations.

Genpact currently has a consensus target price of $40.25, indicating a potential upside of 34.10%. ExlService has a consensus target price of $40.50, indicating a potential upside of 50.95%. Given ExlService's stronger consensus rating and higher probable upside, analysts clearly believe ExlService is more favorable than Genpact.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genpact	0 Sell rating(s)	6 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
ExlService	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67

Genpact has higher revenue and earnings than ExlService. Genpact is trading at a lower price-to-earnings ratio than ExlService, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genpact	$5.08B	1.00	$552.49M	$3.26	9.21
ExlService	$2.09B	1.96	$251.02M	$1.57	17.09

Genpact has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market. Comparatively, ExlService has a beta of 0.84, suggesting that its share price is 16% less volatile than the broader market.

96.0% of Genpact shares are held by institutional investors. Comparatively, 92.9% of ExlService shares are held by institutional investors. 1.6% of Genpact shares are held by company insiders. Comparatively, 3.7% of ExlService shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Genpact had 5 more articles in the media than ExlService. MarketBeat recorded 8 mentions for Genpact and 3 mentions for ExlService. ExlService's average media sentiment score of 0.82 beat Genpact's score of 0.51 indicating that ExlService is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Genpact	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
ExlService	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

ExlService has a net margin of 11.66% compared to Genpact's net margin of 11.04%. ExlService's return on equity of 28.50% beat Genpact's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Genpact	11.04%	22.70%	10.42%
ExlService	11.66%	28.50%	15.48%

Summary

ExlService beats Genpact on 11 of the 16 factors compared between the two stocks.

How does Genpact compare to Broadridge Financial Solutions?

Genpact (NYSE:G) and Broadridge Financial Solutions (NYSE:BR) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, dividends and institutional ownership.

Genpact has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market. Comparatively, Broadridge Financial Solutions has a beta of 0.89, meaning that its stock price is 11% less volatile than the broader market.

Genpact presently has a consensus target price of $40.25, indicating a potential upside of 34.10%. Broadridge Financial Solutions has a consensus target price of $221.57, indicating a potential upside of 53.76%. Given Broadridge Financial Solutions' stronger consensus rating and higher possible upside, analysts plainly believe Broadridge Financial Solutions is more favorable than Genpact.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genpact	0 Sell rating(s)	6 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Broadridge Financial Solutions	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

96.0% of Genpact shares are held by institutional investors. Comparatively, 90.0% of Broadridge Financial Solutions shares are held by institutional investors. 1.6% of Genpact shares are held by company insiders. Comparatively, 1.1% of Broadridge Financial Solutions shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Broadridge Financial Solutions had 11 more articles in the media than Genpact. MarketBeat recorded 19 mentions for Broadridge Financial Solutions and 8 mentions for Genpact. Broadridge Financial Solutions' average media sentiment score of 1.06 beat Genpact's score of 0.51 indicating that Broadridge Financial Solutions is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Genpact	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Broadridge Financial Solutions	12 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Broadridge Financial Solutions has a net margin of 15.03% compared to Genpact's net margin of 11.04%. Broadridge Financial Solutions' return on equity of 40.14% beat Genpact's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Genpact	11.04%	22.70%	10.42%
Broadridge Financial Solutions	15.03%	40.14%	12.87%

Genpact pays an annual dividend of $0.75 per share and has a dividend yield of 2.5%. Broadridge Financial Solutions pays an annual dividend of $3.90 per share and has a dividend yield of 2.7%. Genpact pays out 23.0% of its earnings in the form of a dividend. Broadridge Financial Solutions pays out 41.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Genpact has raised its dividend for 6 consecutive years and Broadridge Financial Solutions has raised its dividend for 18 consecutive years. Broadridge Financial Solutions is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Broadridge Financial Solutions has higher revenue and earnings than Genpact. Genpact is trading at a lower price-to-earnings ratio than Broadridge Financial Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genpact	$5.08B	1.00	$552.49M	$3.26	9.21
Broadridge Financial Solutions	$6.89B	2.42	$839.50M	$9.34	15.43

Summary

Broadridge Financial Solutions beats Genpact on 16 of the 19 factors compared between the two stocks.

How does Genpact compare to Jack Henry & Associates?

Genpact (NYSE:G) and Jack Henry & Associates (NASDAQ:JKHY) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership, media sentiment and valuation.

Genpact has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market. Comparatively, Jack Henry & Associates has a beta of 0.57, meaning that its stock price is 43% less volatile than the broader market.

Genpact has higher revenue and earnings than Jack Henry & Associates. Genpact is trading at a lower price-to-earnings ratio than Jack Henry & Associates, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genpact	$5.08B	1.00	$552.49M	$3.26	9.21
Jack Henry & Associates	$2.38B	4.37	$455.75M	$7.15	20.44

In the previous week, Genpact had 2 more articles in the media than Jack Henry & Associates. MarketBeat recorded 8 mentions for Genpact and 6 mentions for Jack Henry & Associates. Jack Henry & Associates' average media sentiment score of 1.10 beat Genpact's score of 0.51 indicating that Jack Henry & Associates is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Genpact	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Jack Henry & Associates	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Genpact currently has a consensus price target of $40.25, suggesting a potential upside of 34.10%. Jack Henry & Associates has a consensus price target of $186.07, suggesting a potential upside of 27.32%. Given Genpact's higher possible upside, equities analysts clearly believe Genpact is more favorable than Jack Henry & Associates.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genpact	0 Sell rating(s)	6 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Jack Henry & Associates	0 Sell rating(s)	4 Hold rating(s)	9 Buy rating(s)	2 Strong Buy rating(s)	2.87

Genpact pays an annual dividend of $0.75 per share and has a dividend yield of 2.5%. Jack Henry & Associates pays an annual dividend of $2.44 per share and has a dividend yield of 1.7%. Genpact pays out 23.0% of its earnings in the form of a dividend. Jack Henry & Associates pays out 34.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Genpact has increased its dividend for 6 consecutive years and Jack Henry & Associates has increased its dividend for 35 consecutive years. Genpact is clearly the better dividend stock, given its higher yield and lower payout ratio.

96.0% of Genpact shares are held by institutional investors. Comparatively, 98.8% of Jack Henry & Associates shares are held by institutional investors. 1.6% of Genpact shares are held by insiders. Comparatively, 0.6% of Jack Henry & Associates shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Jack Henry & Associates has a net margin of 20.64% compared to Genpact's net margin of 11.04%. Jack Henry & Associates' return on equity of 24.03% beat Genpact's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Genpact	11.04%	22.70%	10.42%
Jack Henry & Associates	20.64%	24.03%	17.02%

Summary

Jack Henry & Associates beats Genpact on 12 of the 20 factors compared between the two stocks.

How does Genpact compare to WEX?

Genpact (NYSE:G) and WEX (NYSE:WEX) are both mid-cap data processing & outsourced services companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and valuation.

Genpact currently has a consensus price target of $40.25, suggesting a potential upside of 34.10%. WEX has a consensus price target of $173.70, suggesting a potential upside of 11.39%. Given Genpact's higher possible upside, analysts clearly believe Genpact is more favorable than WEX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genpact	0 Sell rating(s)	6 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
WEX	0 Sell rating(s)	10 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.33

Genpact has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market. Comparatively, WEX has a beta of 0.85, meaning that its share price is 15% less volatile than the broader market.

Genpact has higher revenue and earnings than WEX. Genpact is trading at a lower price-to-earnings ratio than WEX, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genpact	$5.08B	1.00	$552.49M	$3.26	9.21
WEX	$2.66B	2.03	$304.10M	$8.91	17.50

96.0% of Genpact shares are owned by institutional investors. Comparatively, 97.5% of WEX shares are owned by institutional investors. 1.6% of Genpact shares are owned by company insiders. Comparatively, 1.4% of WEX shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, WEX had 11 more articles in the media than Genpact. MarketBeat recorded 19 mentions for WEX and 8 mentions for Genpact. WEX's average media sentiment score of 0.52 beat Genpact's score of 0.51 indicating that WEX is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Genpact	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
WEX	5 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

WEX has a net margin of 11.50% compared to Genpact's net margin of 11.04%. WEX's return on equity of 42.66% beat Genpact's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Genpact	11.04%	22.70%	10.42%
WEX	11.50%	42.66%	3.33%

Summary

WEX beats Genpact on 11 of the 16 factors compared between the two stocks.

Get Genpact News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding G and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

G vs. The Competition

Export

Metric	Genpact	IT Services Industry	Computer Sector	NYSE Exchange
Market Cap	$5.12B	$12.01B	$38.49B	$23.48B
Dividend Yield	2.49%	2.78%	3.16%	4.18%
P/E Ratio	9.21	44.05	168.30	30.84
Price / Sales	1.00	7.67	597.35	20.80
Price / Cash	7.94	22.32	46.08	32.60
Price / Book	2.03	3.09	9.29	4.75
Net Income	$552.49M	$522.20M	$1.07B	$1.07B
7 Day Performance	-0.40%	-3.04%	-1.97%	-0.13%
1 Month Performance	6.78%	-1.05%	-2.86%	1.46%
1 Year Performance	-34.53%	-26.24%	137.30%	16.19%

Genpact Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
G Genpact	4.9462 of 5 stars	$30.02 -0.5%	$40.25 +34.1%	-32.8%	$5.12B	$5.08B	9.21	146,500	Dividend Announcement
CCRN Cross Country Healthcare	2.0573 of 5 stars	$13.25 +0.1%	$12.05 -9.1%	-0.8%	$427.74M	$1.05B	N/A	6,784	High Trading Volume
EXLS ExlService	4.4242 of 5 stars	$28.18 +0.1%	$40.50 +43.7%	-35.8%	$4.30B	$2.09B	17.95	65,000	Upcoming Earnings
BR Broadridge Financial Solutions	4.9578 of 5 stars	$149.90 0.0%	$221.57 +47.8%	-40.0%	$17.34B	$6.89B	16.05	15,000	News Coverage Positive News
JKHY Jack Henry & Associates	4.9707 of 5 stars	$153.16 +1.0%	$186.07 +21.5%	-15.8%	$10.78B	$2.38B	21.42	7,400	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:G) was last updated on 7/22/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Genpact (G) Competitors

G vs. CCRN, EXLS, BR, JKHY, and WEX

How does Genpact compare to Cross Country Healthcare?

Summary

How does Genpact compare to ExlService?

Summary

How does Genpact compare to Broadridge Financial Solutions?

Summary

How does Genpact compare to Jack Henry & Associates?

Summary

How does Genpact compare to WEX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

G vs. The Competition

Genpact Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Genpact (G) Competitors

G vs. CCRN, EXLS, BR, JKHY, and WEX

How does Genpact compare to Cross Country Healthcare?

Is G or CCRN more profitable?

Which has more volatility and risk, G or CCRN?

Do insiders & institutionals hold more shares of G or CCRN?

Do analysts rate G or CCRN?

Which has stronger earnings & valuation, G or CCRN?

Does the media prefer G or CCRN?

Summary

How does Genpact compare to ExlService?

Do analysts rate G or EXLS?

Which has stronger valuation and earnings, G or EXLS?

Which has more risk & volatility, G or EXLS?

Do insiders & institutionals believe in G or EXLS?

Does the media prefer G or EXLS?

Is G or EXLS more profitable?

Summary

How does Genpact compare to Broadridge Financial Solutions?

Which has more volatility and risk, G or BR?

Do analysts rate G or BR?

Do institutionals and insiders hold more shares of G or BR?

Does the media favor G or BR?

Is G or BR more profitable?

Is G or BR a better dividend stock?

Which has better earnings & valuation, G or BR?

Summary

How does Genpact compare to Jack Henry & Associates?

Which has more volatility & risk, G or JKHY?

Which has preferable valuation & earnings, G or JKHY?

Does the media prefer G or JKHY?

Do analysts recommend G or JKHY?

Is G or JKHY a better dividend stock?

Do insiders & institutionals have more ownership in G or JKHY?

Is G or JKHY more profitable?

Summary

How does Genpact compare to WEX?

Do analysts recommend G or WEX?

Which has more volatility & risk, G or WEX?

Which has preferable earnings & valuation, G or WEX?

Do institutionals & insiders hold more shares of G or WEX?

Does the media favor G or WEX?

Is G or WEX more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

G vs. The Competition

Genpact Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools